Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Wound Healing: A Cellular Perspective
Rodrigues, M., Kosaric, N., Bonham, C. A., & Gurtner, G. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00067.2017 · Cited by 3,013
“Next, primary hemostasis and secondary hemostasis occur via two concurrent and mechanistically intertwined pathways (129).”
BackgroundThrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
“However, at sites of vessel injury, platelets are rapidly activated by stimulus-dependent mobilization of [Ca2+]i, a precursor to thrombus formation and hemostasis (Rink and Sage, 1990; Furie and Furie, 2008).”
InfluentialClassification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
“…trigger thrombus formation in vivo (Biró et al., 2003), are abundantly present in human atherosclerotic plaques (Mallat et al., 1999), and may be deposited at a site of vascular injury by binding to activated platelets (Furie and Furie, 2004; Del Conde et al., 2005; Furie and Furie, 2008).”
BackgroundRossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
“Fibrinogen is the final component in the coagulation cascade, the ligand for platelet aggregation and therefore key to effective coagulation and platelet function [280, 420].”
BackgroundSpahn, D. R., Bouillon, B., Cerny, V., Duranteau, J., Filipescu, D., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,269
“Fibrinogen is the final component in the coagulation cascade, the ligand for platelet aggregation and therefore key to effective coagulation and platelet function [377, 639].”
BackgroundBlood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
Patterson, S. D., Hughes, L., Warmington, S., Burr, J., Scott, B. R., Owens, J., Abe, T., Nielsen, J. L., Libardi, C. A., Laurentino, G., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00533 · Cited by 917
“A thrombus is a solid mass of platelets, red blood cells, and fibrin mesh that typically forms as a response to vessel wall injury and is part of the normal healing cascade (Furie and Furie, 2008).”
BackgroundManagement of bleeding and coagulopathy following major trauma: an updated European guideline
Spahn, D. R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2013) · Critical Care · doi:10.1186/cc12685 · Cited by 977
“(Grade 2C) Rationale Fibrinogen is the final component in the coagulation cascade, the ligand for platelet aggregation and, therefore, key to effective coagulation and platelet function [233,369].”
BackgroundPlatelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
Müller, F., Mutch, N. J., Schenk, W. A., Smith, S. A., Esterl, L., Spronk, H. M., Schmidbauer, S., Gahl, W. A., Morrissey, J. H., & Renné, T. (2009) · Cell · doi:10.1016/j.cell.2009.11.001 · Cited by 831
“Platelets play a pivotal role in vascular occlusive disease (Furie and Furie, 2008; Ruggeri, 2002).”
InfluentialManagement of bleeding following major trauma: an updated European guideline
Rossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Hunt, B. J., Komadina, R., Nardi, G., Neugebauer, E., et al. (2010) · Critical Care · doi:10.1186/cc8943 · Cited by 818
“Rationale The formation of fibrin is a key step in blood coagulation [222,279], and hypofibrinogenemia is a usual component of complex coagulopathies associated with massive bleeding.”
BackgroundArterial thrombosis—insidious, unpredictable and deadly
Jackson, S. P. (2011) · Nature Medicine · doi:10.1038/nm.2515 · Cited by 685
“Thrombosis is primarily mediated by platelets and fibri”
BackgroundThe Hemostatic System as a Modulator of Atherosclerosis
Borissoff, J. I., Spronk, H. M. H., & ten Cate, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011670 · Cited by 569
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
“Whereas the prothrombotic effects of collagen and tissue factor in the vascular wall protect the tissue from hemorrhage, antithrombotic and profibrinolytic factors in the endothelium (NO, prostacylin, CD39, plasminogen activators, etc.) prevent vascular occlusion [ 29 ].”
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
TAM Receptor Signaling in Immune Homeostasis
Rothlin, C. V., Carrera-Silva, E. A., Bosurgi, L., & Ghosh, S. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112103 · Cited by 510
“Vascular damage results in the exposure of subendothelial collagen and von Willebrand factor, leading to the adhesion and initial activation of platelets (95).”
BackgroundZwicker, J. I., Liebman, H. A., Neuberg, D., Lacroix, R., Bauer, K. A., Furie, B. C., & Furie, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0371 · Cited by 479
“6831 Clin Cancer Res 2009;15(22) November 15, 2009 www.”
InfluentialSelf-citationThrombosis and platelets: an update
Koupenova, M., Kehrel, B. E., Corkrey, H. A., & Freedman, J. E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw550 · Cited by 451
Exosomes from adipose‐derived stem cells and application to skin wound healing
An, Y., Lin, S., Tan, X., Zhu, S., Nie, F., Zhen, Y., Gu, L., Zhang, C., Wang, B., Wei, W., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.12993 · Cited by 472
Yang, H., Kim, A., David, T., Palmer, D., Jin, T., Tien, J., Huang, F., Cheng, T., Coughlin, S. R., Jan, Y. N., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.036 · Cited by 467
“Platelets are accumulated at sites of vascular injury and are activated by exposed subendothelial factors such as collagen or by thrombin generated from the coagulation cascade pathway (Furie and Furie, 2008).”
Risk factors for venous and arterial thrombosis.
Previtali, E., Bucciarelli, P., Passamonti, S. M., & Martinelli, I. (2011) · PubMed · doi:10.2450/2010.0066-10 · Cited by 447
New insights into the mechanisms of venous thrombosis
Mackman, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60229 · Cited by 436
“Receptor-mediated binding of leukocytes and MVs to activated endothelium P-selectin appears to be a key endothelial cell receptor that captures circulating leukocytes and leukocyte-derived MVs expressing PSGL-1 (Figure 2) (72).”
BackgroundInfluentialPlatelet receptors and signaling in the dynamics of thrombus formation
Rivera, J., Lozano, M. L., Navarro-Nunez, L., & Vicente, V. (2009) · Haematologica · doi:10.3324/haematol.2008.003178 · Cited by 416
“In vivo, experiments also show that thrombin activity is distributed throughout the platelet thrombus and not only at the thrombus-blood interface, indicating that the arterial thrombi are porous and allow the flow of agonists within.(6) Thrombin is perhaps the most effective platelet activator, and provokes a full ra…”
BackgroundAntiplatelet therapies for the treatment of cardiovascular disease
Michelson, A. D. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2957 · Cited by 407
Bioactive Materials Promote Wound Healing through Modulation of Cell Behaviors
Li, R., Liu, K., Huang, X., Li, D., Ding, J., Liu, B., & Chen, X. (2022) · Advanced Science · doi:10.1002/advs.202105152 · Cited by 376
Organic NIR-II molecule with long blood half-life for in vivo dynamic vascular imaging
Li, B., Zhao, M., Feng, L., Dou, C., Ding, S., Zhou, G., Lu, L., Zhang, H., Chen, F., Li, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16924-z · Cited by 374
Wound Healing: A Comprehensive Review
Almadani, Y. H., Vorstenbosch, J., Davison, P. G., & Murphy, A. M. (2021) · Seminars in Plastic Surgery · doi:10.1055/s-0041-1731791 · Cited by 310
Xu, X. R., Zhang, D., Oswald, B. E., Carrim, N., Wang, X., Hou, Y., Zhang, Q., Lavalle, C., McKeown, T., Marshall, A. H., et al. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1200008 · Cited by 338
Recent advances in molecular mechanisms of skin wound healing and its treatments
Mamun, A. A., Shao, C., Geng, P., Wang, S., & Xiao, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395479 · Cited by 284
Arterial thrombus formation in cardiovascular disease
Lippi, G., Franchini, M., & Targher, G. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.91 · Cited by 321
Strategies to improve the EPR effect: A mechanistic perspective and clinical translation
Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
“Platelets adhere avidly at sites of clinical or experimental vascular injury, a critical first step in hemostasis and thrombosis [36, 38, 39] (Fig.”
BackgroundInfluentialJain, A., Barrile, R., van der Meer, A., Mammoto, A., Mammoto, T., De Ceunynck, K., Aisiku, O., Otieno, M., Louden, C., Hamilton, G., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.742 · Cited by 325
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
Kvietys, P. R., & Granger, D. N. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.002 · Cited by 312
“ical signals that downregulate these mechanisms can initiate coagulation [527,528,539,541].”
BackgroundAzeredo, E. L. D., Monteiro, R. Q., & de-Oliveira Pinto, L. M. (2015) · Mediators of Inflammation · doi:10.1155/2015/313842 · Cited by 288
“Platelets are anucleated circulating cells in mammals approximately 2 𝜇m in diameter and are derived from megakaryocytes within the bone marrow [56, 57].”
BackgroundWound Repair: Toward Understanding and Integration of Single-Cell and Multicellular Wound Responses
Sonnemann, K. J., & Bement, W. M. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154251 · Cited by 312
“Excessive production of thrombin, for example, can result in clot formation inside blood vessels, which can lead to cardiac arrest or stroke (Furie & Furie 2008).”
BackgroundThe discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., & Misselwitz, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3185 · Cited by 297
Mega, J. L., & Simon, T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60243-4 · Cited by 284
Current and future antiplatelet therapies: emphasis on preserving haemostasis
McFadyen, J. D., Schaff, M., & Peter, K. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.206 · Cited by 281
Funderburg, N. T., Mayne, E., Sieg, S. F., Asaad, R., Jiang, W., Kalinowska, M., Luciano, A. A., Stevens, W., Rodriguez, B., Brenchley, J. M., et al. (2010) · Blood · doi:10.1182/blood-2009-03-210179 · Cited by 285
Blood coagulation on biomaterials requires the combination of distinct activation processes
Sperling, C., Fischer, M., Maitz, M. F., & Werner, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.044 · Cited by 281
“They also release intracellular granules containing molecules including coagulation factors VII and XI, the adhesion molecules P-selectin and vWF, serotonin and platelet factor 4 (PF4), all of which impact further the activation of other platelets, coagulation and inflammation [29,32].”
BackgroundThe role of transcription-independent damage signals in the initiation of epithelial wound healing
Cordeiro, J. V., & Jacinto, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3541 · Cited by 273
Hundelshausen, P. V., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 271
“GPVI is the major agonist for initial platelet activation and granule release (28).”
BackgroundLi, M., Li, J., Chen, J., Liu, Y., Cheng, X., Yang, F., & Gu, N. (2020) · ACS Nano · doi:10.1021/acsnano.9b08587 · Cited by 279
Rivaroxaban: A New Oral Factor Xa Inhibitor
Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., Mueck, W., & Laux, V. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.202978 · Cited by 276
Carbohydrate-based drugs launched during 2000−2021
Cao, X., Du, X., Jiao, H., An, Q., Chen, R., Fang, P., Wang, J., & Yu, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.020 · Cited by 267
Alternatives to blood transfusion
Spahn, D. R., & Goodnough, L. T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60808-9 · Cited by 261
Early Anticoagulation Is Associated With Reduced Mortality for Acute Pulmonary Embolism
Smith, S. B., Geske, J. B., Maguire, J. M., Zane, N. A., Carter, R. E., & Morgenthaler, T. I. (2010) · Chest · doi:10.1378/chest.09-0959 · Cited by 267
Plant Polyphenols and Their Potential Benefits on Cardiovascular Health: A Review
Iqbal, I., Wilairatana, P., Saqib, F., Nasir, B., Wahid, M., Latif, M. F., Iqbal, A., Naz, R., & Mubarak, M. S. (2023) · Molecules · doi:10.3390/molecules28176403 · Cited by 247
Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models
Grover, S. P., & Mackman, N. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.312130 · Cited by 239
Ectonucleotidases as Regulators of Purinergic Signaling in Thrombosis, Inflammation, and Immunity
Deaglio, S., & Robson, S. C. (2011) · Advances in Pharmacology · doi:10.1016/b978-0-12-385526-8.00010-2 · Cited by 250
“The interested reader is referred to an excellent recent review of this topic by Furie and Furie (2008).”
BackgroundInfluentialDiagnostic markers of acute myocardial infarction
MYTHILI, S., & MALATHI, N. (2015) · Biomedical Reports · doi:10.3892/br.2015.500 · Cited by 249
“The tissue factor expressed by the macrophages activates the platelets eventually leading to the formation of intraluminal thrombus (9,10).”
BackgroundOrai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation
Braun, A., Varga-Szabo, D., Kleinschnitz, C., Pleines, I., Bender, M., Austinat, M., Bösl, M., Stoll, G., & Nieswandt, B. (2009) · Blood · doi:10.1182/blood-2008-07-171611 · Cited by 248
Strategies to improve chitosan hemocompatibility: A review
Balan, V., & Verestiuc, L. (2014) · European Polymer Journal · doi:10.1016/j.eurpolymj.2014.01.033 · Cited by 246
“According to Furie and Furie [49], the blood coagulation mechanism triggered by positive surfaces is mainly related to extrinsic pathway.”
BackgroundPlatelet thrombin receptor antagonism and atherothrombosis
Angiolillo, D. J., Capodanno, D., & Goto, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp504 · Cited by 251
“mediate thrombosis, the major pathogenic event in disease progression.(2) Excessive platelet activation subsequent to plaque”
BackgroundFibrin(ogen) in human disease: both friend and foe
Vilar, R., Fish, R. J., Casini, A., & Neerman-Arbez, M. (2020) · Haematologica · doi:10.3324/haematol.2019.236901 · Cited by 236
“Bleeding or hemorrhage is the escape of blood from the closed cardiovascular system due to damaged blood vessels.(16) The natural control of bleeding is known as hemostasis.”
BackgroundEngineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
Hu, Q., Qian, C., Sun, W., Wang, J., Chen, Z., Bomba, H. N., Xin, H., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201603463 · Cited by 240
Chitosan/gelatin composite sponge is an absorbable surgical hemostatic agent
Lan, G., Lu, B., Wang, T., Wang, L., Chen, J., Yu, K., Liu, J., Dai, F., & Wu, D. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.10.039 · Cited by 237
Nanoparticles and The Blood Coagulation System. Part II: Safety Concerns
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2013) · Nanomedicine · doi:10.2217/nnm.13.49 · Cited by 228
Xu, J., Zhang, Y., Xu, J., Liu, G., Di, C., Zhao, X., Li, X., Li, Y., Pang, N., Yang, C., et al. (2020) · Advanced Materials · doi:10.1002/adma.201905145 · Cited by 234
Disorders of Hemostasis Associated with Chronic Kidney Disease
Jalal, D., Chonchol, M., & Targher, G. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1248722 · Cited by 231
“These platelet agonists amplify the signal for thrombus formation by activating other platelets and recruiting them to the site of clot formation.(1) Thromboxane A2 is synthesized in the platelets by way of cyclooxygenase (COX)-1 from the arachidonic acid released by the neighboring endothelial cells, and it functions…”
BackgroundExosomes in stroke pathogenesis and therapy
Zhang, Z. G., & Chopp, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81133 · Cited by 225
“Platelets, along with thrombin and fibrin resulting from tissue factor– activated blood coagulation, are the primary contributors to thrombus development at the site of the occluded artery (14, 15).”
BackgroundBioprinted thrombosis-on-a-chip
Zhang, Y. S., Davoudi, F., Walch, P., Manbachi, A., Luo, X., Dell'Erba, V., Miri, A. K., Albadawi, H., Arneri, A., Li, X., et al. (2016) · Lab on a Chip · doi:10.1039/c6lc00380j · Cited by 227
Tissue Factor, Blood Coagulation, and Beyond: An Overview
Chu, A. J. (2011) · International Journal of Inflammation · doi:10.4061/2011/367284 · Cited by 222
“The extrinsic pathway plays an integral role in blood coagulation complemented by the intrinsic pathway that ensures FIIa regeneration and clot production (Figure 2, left panel) (for review, see [3, 4, 10, 67]).”
BackgroundProtein disulfide isomerase a multifunctional protein with multiple physiological roles
Ali Khan, H., & Mutus, B. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00070 · Cited by 215
“This causes receptors on platelets to bind fibrinogen resulting in the increase adhesion of the platelets and the formation of thrombi(Ma et al., 2007; Furie and Furie, 2008).”
BackgroundXIAP as a ubiquitin ligase in cellular signaling
Galbán, S., & Duckett, C. S. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.81 · Cited by 215
“The ordered hierarchy of events in which caspases are sequentially activated is itself a specialized signal transduction pathway, similar to the paradigm of the tissue factor pathway that regulates blood coagulation.(46) In addition, it is”
Xenotransplantation: Current Status in Preclinical Research
Lu, T., Yang, B., Wang, R., & Qin, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03060 · Cited by 213
Platelet function following trauma: A Multiple Electrode Aggregometry study
Solomon, C., Traintinger, S., Ziegler, B., Hanke, A., Rahe-Meyer, N., Voelckel, W., & Schöchl, H. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-03-0175 · Cited by 215
“Furthermore, the platelet membrane acts as a surface for amplification of the haemostatic process, as well as binding and activation of coagulation factors (6).”
BackgroundAbbasian, M., Massoumi, B., Mohammad-Rezaei, R., Samadian, H., & Jaymand, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.197 · Cited by 214
Leukocyte-Derived Microparticles in Vascular Homeostasis
Angelillo-Scherrer, A. (2012) · Circulation Research · doi:10.1161/circresaha.110.233403 · Cited by 206
Jonidi Shariatzadeh, F., Currie, S., Logsetty, S., Spiwak, R., & Liu, S. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101350 · Cited by 198
Cell-derived vesicles exposing coagulant tissue factor in saliva
Berckmans, R. J., Sturk, A., van Tienen, L. M., Schaap, M. C. L., & Nieuwland, R. (2011) · Blood · doi:10.1182/blood-2010-06-290460 · Cited by 198
Endothelial dysfunction and immunothrombosis in sepsis
Maneta, E., Aivalioti, E., Tual-Chalot, S., Emini Veseli, B., Gatsiou, A., Stamatelopoulos, K., & Stellos, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1144229 · Cited by 187
“The process of thrombus formation inside a blood vessel, which can lead to partial or total vessel occlusion, requires platelets’ accumulation and activation as well as activation of the coagulation cascade (14).”
BackgroundGut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
Zhu, Y., Li, Q., & Jiang, H. (2020) · APMIS · doi:10.1111/apm.13038 · Cited by 196
“It is suggested that intracellular cytosolic calcium [Ca]i is the precursor to thrombus formation (72); intriguingly, TMAO can promote”
BackgroundPostinjury Coagulopathy Management: Goal Directed Resuscitation via POC Thrombelastography
Kashuk, J. L., Moore, E. E., Sawyer, M., Le, T., Johnson, J., Biffl, W. L., Cothren, C. C., Barnett, C., Stahel, P., Sillman, C. C., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181d3599c · Cited by 209
Procoagulant mechanisms in tumour cells
Falanga, A., Panova-Noeva, M., & Russo, L. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.12.009 · Cited by 201
Xu, J., Wang, X., Yin, H., Cao, X., Hu, Q., Lv, W., Xu, Q., Gu, Z., & Xin, H. (2019) · ACS Nano · doi:10.1021/acsnano.9b01798 · Cited by 198
Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice
Deppermann, C., Cherpokova, D., Nurden, P., Schulz, J.-N., Thielmann, I., Kraft, P., Vögtle, T., Kleinschnitz, C., Dütting, S., Krohne, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69210 · Cited by 200
“Platelet activation and aggregation at sites of vessel wall injury are crucial to prevent posttraumatic blood loss but may also be major participants in diseases such as myocardial infarction and stroke (1, 2).”
Savcı, Y., Kırbaş, O. K., Bozkurt, B. T., Abdik, E. A., Taşlı, P. N., Şahin, F., & Abdik, H. (2021) · Food & Function · doi:10.1039/d0fo02953j · Cited by 190
The role of neutrophils in thrombosis
Kapoor, S., Opneja, A., & Nayak, L. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.08.005 · Cited by 190
Nanomedicine in Healing Chronic Wounds: Opportunities and Challenges
Sharifi, S., Hajipour, M. J., Gould, L., & Mahmoudi, M. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00346 · Cited by 194
Riegger, J., Byrne, R. A., Joner, M., Chandraratne, S., Gershlick, A. H., ten Berg, J. M., Adriaenssens, T., Guagliumi, G., Godschalk, T. C., Neumann, F.-J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv419 · Cited by 193
Wang, S., Guo, X., Xiu, W., Liu, Y., Ren, L., Xiao, H., Yang, F., Gao, Y., Xu, C., & Wang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz8204 · Cited by 194
Vascular cognitive impairment and dementia
Gorelick, P. B., Counts, S. E., & Nyenhuis, D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.015 · Cited by 184
“Together, these signaling mediators coordinate vessel tone and neurovascular coupling, immune surveillance, and hemostasis following injury [22-24].”
BackgroundPAMPs and DAMPs as triggers for DIC
Ito, T. (2014) · Journal of Intensive Care · doi:10.1186/s40560-014-0065-0 · Cited by 185
“Platelet thrombus formation and fibrin deposition occur concomitantly as thrombin activates platelets, and activated platelets expose phosphatidylserine on their membrane surface to provide a scaffold for blood-clotting enzyme complexes [3].”
BackgroundFlavonoids and platelet aggregation: A brief review
Faggio, C., Sureda, A., Morabito, S., Sanches-Silva, A., Mocan, A., Nabavi, S. F., & Nabavi, S. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.04.009 · Cited by 193
A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques
Reininger, A. J., Bernlochner, I., Penz, S. M., Ravanat, C., Smethurst, P., Farndale, R. W., Gachet, C., Brandl, R., & Siess, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.051 · Cited by 186
Cancer, Clots and Consensus: New Understanding of an Old Problem
Lyman, G. H., & Khorana, A. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3032 · Cited by 190
“The underlying biologic factors associated with the increased risk of thrombosis in patients with cancer include the activation of thrombin and fibrin formation both directly by the release of procoagulants by tumor cells and indirectly by the activation of endothelial cells, leukocytes, and platelets by cytokines and…”
BackgroundPI3K/Akt in platelet integrin signaling and implications in thrombosis
Guidetti, G. F., Canobbio, I., & Torti, M. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.06.001 · Cited by 184
Nitric Oxide Donors for Cardiovascular Implant Applications
Naghavi, N., de Mel, A., Alavijeh, O. S., Cousins, B. G., & Seifalian, A. M. (2013) · Small · doi:10.1002/smll.201200458 · Cited by 188
Kim, K., Hahm, E., Li, J., Holbrook, L.-M., Sasikumar, P., Stanley, R. G., Ushio-Fukai, M., Gibbins, J. M., & Cho, J. (2013) · Blood · doi:10.1182/blood-2013-03-492504 · Cited by 183
“Following vascular injury, platelets rapidly adhere to activated endothelial cells and/or subendothelial matrix proteins such as collagen and von Willebrand factor through receptor–ligand interactions.(1) Subsequently, activated platelets expose P-selectin from a-granules to the plasma membrane and release other granu…”
BackgroundInfluentialArterial Thromboembolism: Risks, realities and a rational first-line approach
Fuentes, V. L. (2012) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x12451547 · Cited by 170
Fibrinogen and Altered Hemostasis in Alzheimer's Disease
Cortes-Canteli, M., Zamolodchikov, D., Ahn, H. J., Strickland, S., & Norris, E. H. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120820 · Cited by 181
“dysregulated hemostasis [57].”
Thrombotic risk factors: Basic pathophysiology
Martinelli, I., Bucciarelli, P., & Mannucci, P. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9cbd9 · Cited by 177
“This complex produces small amounts of thrombin and promotes thrombus formation through the activation of coagulation reactions on the membrane surfaces of activated platelets and microparticles (8).”
BackgroundThrombin generation: What have we learned?
Al Dieri, R., de Laat, B., & Hemker, H. C. (2012) · Blood Reviews · doi:10.1016/j.blre.2012.06.001 · Cited by 177
Leukocytes and the Natural History of Deep Vein Thrombosis: Current Concepts and Future Directions
Saha, P., Humphries, J., Modarai, B., Mattock, K., Waltham, M., Evans, C. E., Ahmad, A., Patel, A. S., Premaratne, S., Lyons, O. T. A., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213405 · Cited by 178
Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians
Vazquez-Garza, E., Jerjes-Sanchez, C., Navarrete, A., Joya-Harrison, J., & Rodriguez, D. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-017-1528-7 · Cited by 176
“Exposed collagen triggers the activation and accumulation of platelets, whereas ITF initiates the generation of thrombin, converting fibrinogen to fibrin and activating platelets [3].”
BackgroundP2X7 receptor signaling contributes to tissue factor–dependent thrombosis in mice
Furlan-Freguia, C., Marchese, P., Gruber, A., Ruggeri, Z. M., & Ruf, W. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46129 · Cited by 169
Huang, H., Hou, J., Li, M., Wei, F., Liao, Y., & Xi, B. (2025) · Science Advances · doi:10.1126/sciadv.adr8243 · Cited by 210
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.